2B70.DE vs. ARKG

Last updated Apr 2, 2026

Compare and contrast key facts about iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and ARK Genomic Revolution Multi-Sector ETF (ARKG).

2B70.DE and ARKG are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. 2B70.DE is a passively managed fund by iShares that tracks the performance of the Nasdaq Biotechnology. It was launched on Oct 19, 2017. ARKG is an actively managed fund by ARK. It was launched on Oct 31, 2014.

Performance

2B70.DE vs. ARKG - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and ARK Genomic Revolution Multi-Sector ETF (ARKG). The values are adjusted to include any dividend payments, if applicable.

2B70.DE vs. ARKG - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF	3.64%	18.62%	4.60%	2.56%	-6.29%	7.59%	14.52%	30.18%	-7.35%	2.65%
ARKG ARK Genomic Revolution Multi-Sector ETF	-5.05%	8.44%	-23.50%	12.74%	-51.05%	-28.98%	157.29%	47.25%	3.37%	-3.92%

Different Trading Currencies

2B70.DE is traded in EUR, while ARKG is traded in USD. To make them comparable, the ARKG values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, 2B70.DE achieves a 3.64% return, which is significantly higher than ARKG's -5.05% return.

2B70.DE

• 1D: 1.60%
• 1M: -0.58%
• YTD: 3.64%
• 6M: 18.58%
• 1Y: 29.69%
• 3Y*: 10.78%
• 5Y*: 4.95%
• 10Y*: —

ARKG

• 1D: 2.43%
• 1M: -8.48%
• YTD: -5.05%
• 6M: -4.77%
• 1Y: 25.13%
• 3Y*: -5.48%
• 5Y*: -20.88%
• 10Y*: 4.79%

*Multi-year figures are annualized to reflect compound growth (CAGR)

2B70.DE vs. ARKG - Expense Ratio Comparison

2B70.DE has a 0.35% expense ratio, which is lower than ARKG's 0.75% expense ratio.

ARKG

ARK Genomic Revolution Multi-Sector ETF

2B70.DE

iShares Nasdaq US Biotechnology UCITS ETF

Return for Risk

2B70.DE vs. ARKG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

2B70.DE

2B70.DE Risk / Return Rank: 74
2B70.DE Sharpe Ratio Rank: 71
2B70.DE Sortino Ratio Rank: 70
2B70.DE Omega Ratio Rank: 63
2B70.DE Calmar Ratio Rank: 82
2B70.DE Martin Ratio Rank: 86

ARKG

ARKG Risk / Return Rank: 40
ARKG Sharpe Ratio Rank: 39
ARKG Sortino Ratio Rank: 49
ARKG Omega Ratio Rank: 37
ARKG Calmar Ratio Rank: 41
ARKG Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

2B70.DE vs. ARKG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) and ARK Genomic Revolution Multi-Sector ETF (ARKG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	2B70.DE	ARKG	Difference
Sharpe ratio Return per unit of total volatility	1.31	0.56	+0.75
Sortino ratio Return per unit of downside risk	1.83	1.10	+0.73
Omega ratio Gain probability vs. loss probability	1.24	1.13	+0.11
Calmar ratio Return relative to maximum drawdown	2.49	0.86	+1.63
Martin ratio Return relative to average drawdown	10.78	2.20	+8.58
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

2B70.DE vs. ARKG - Sharpe Ratio Comparison

The current 2B70.DE Sharpe Ratio is 1.31, which is higher than the ARKG Sharpe Ratio of 0.56. The chart below compares the historical Sharpe Ratios of 2B70.DE and ARKG, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	2B70.DE	ARKG	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.31	0.56	+0.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.24	-0.48	+0.72
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.12	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.36	0.10	+0.26

Correlation

The correlation between 2B70.DE and ARKG is 0.51, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

2B70.DE vs. ARKG - Dividend Comparison

Neither 2B70.DE nor ARKG has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ARKG ARK Genomic Revolution Multi-Sector ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.62%	0.85%	3.14%	0.82%	1.34%

Drawdowns

2B70.DE vs. ARKG - Drawdown Comparison

The maximum 2B70.DE drawdown since its inception was -30.87%, smaller than the maximum ARKG drawdown of -81.91%. Use the drawdown chart below to compare losses from any high point for 2B70.DE and ARKG.

Drawdown Indicators

	2B70.DE	ARKG	Difference
Max Drawdown Largest peak-to-trough decline	-30.87%	-83.59%	+52.72%
Max Drawdown (1Y) Largest decline over 1 year	-15.56%	-27.51%	+11.95%
Max Drawdown (5Y) Largest decline over 5 years	-30.87%	-80.18%	+49.31%
Max Drawdown (10Y) Largest decline over 10 years	—	-83.59%	—
Current Drawdown Current decline from peak	-1.07%	-75.76%	+74.69%
Average Drawdown Average peak-to-trough decline	-10.17%	-35.32%	+25.15%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.93%	10.24%	-7.31%

Volatility

2B70.DE vs. ARKG - Volatility Comparison

The current volatility for iShares Nasdaq US Biotechnology UCITS ETF (2B70.DE) is 6.80%, while ARK Genomic Revolution Multi-Sector ETF (ARKG) has a volatility of 12.19%. This indicates that 2B70.DE experiences smaller price fluctuations and is considered to be less risky than ARKG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	2B70.DE	ARKG	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.80%	12.19%	-5.39%
Volatility (6M) Calculated over the trailing 6-month period	14.03%	31.44%	-17.41%
Volatility (1Y) Calculated over the trailing 1-year period	22.48%	45.15%	-22.67%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.46%	44.08%	-23.62%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.78%	40.48%	-18.70%